GH Research

ATAI

This biopharmaceutical company develops psychedelic-based treatments and mental health medicines for patients with neurological and psychiatric disorders, such as treatment-resistant depression and anxiety.

Beckley Psytech

The company develops psychedelic-derived medicines to treat patients with neurological and psychiatric conditions such as treatment-resistant depression and rare headache disorders.

Small Pharma Limited

This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.

Compass Pathways

This biotechnology company develops psilocybin-based therapies for patients living with treatment-resistant depression and other mental health conditions.

Gilgamesh

This clinical-stage biotechnology company develops novel psychedelic-related medicines and chemical entities to treat patients with depression and other neuropsychiatric disorders.

Atai Life Sciences

This biopharmaceutical company develops psychedelic and non-psychedelic therapies for patients living with mental health disorders, including depression, anxiety, and addiction.

Reunion Neuroscience

This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.

Mycrodose Therapeutics

This pharmaceutical company develops advanced drug delivery systems for psychedelic and cannabinoid compounds to treat mental health and cognitive degenerative diseases.